Chief Scientific Officer · PALVELLA THERAPEUTICS, INC. (PVLA)

Jeffrey Martini

A named executive officer of PALVELLA THERAPEUTICS in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,866,763

Salary $320,755Stock awards $0Bonus $209,680

FY2023: $614,979

2nd of 5 named executive officers at Palvella Therapeutics by FY2024 total.

5 named officers on file for PALVELLA THERAPEUTICS, FY2024

Jeffrey Martini’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALVELLA THERAPEUTICS’s whole pay program stands against its peers

  • PALVELLA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PVLA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jeffrey Martini’s full pay file as a PDF — free

More than this page: up to 10 years of Jeffrey’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jeffrey Martini compensation by year

PALVELLA THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as PALVELLA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$293,588$320,755
Bonus$39,852$209,680
Stock awards$0$0
Option awards$281,539$1,336,328
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$614,979$1,866,763

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALVELLA THERAPEUTICS, INC. DEF 14A filed April 30, 2025, accession 0001104659-25-042493, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PALVELLA THERAPEUTICS, INC. filed document, accession 0001104659-25-042493. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

$615K
$1.9M
FY23
FY24
SalaryBonusOption awards

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option4,681—$9.79
Option5,532—$9.79
Option126,416—$13.60
Option16,159—$7.53

Per the Outstanding Equity Awards at Fiscal Year-End table in PALVELLA THERAPEUTICS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

20 Form 4 lines since the FY2024 proxy (filed April 30, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-11Sale10b5-11,133$166.762,000
2026-11-11Sale10b5-1600$168.73200
2026-11-11Sale10b5-11,650$164.144,600
2026-11-11Sale10b5-11,467$165.783,133
2026-11-11Exercise or conversion derivative10b5-16,250$0.0020,520
2026-11-11Sale10b5-11,200$167.75800
2026-11-11Exercise or conversion10b5-16,250$9.796,250
2026-11-11Sale10b5-1200$169.780

The 8 most recent of 20 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

PALVELLA THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Wesley KaupinenPresident and Chief Executive Officer$5,436,064
Jeffrey Martini · this pageChief Scientific Officer$1,866,763
Stephen YoderFormer Chief Executive Officer$1,426,204
Kathleen GoinChief Operating Officer$1,124,572
Thomas BuresFormer Chief Financial Officer$943,699

The full PALVELLA THERAPEUTICS compensation record

free company brief

This page is one person within PALVELLA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALVELLA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeffrey Martini's compensation dossier · One-time report. No refunds.